NCT04040959View on ClinicalTrials.gov

Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

PHASE2RecruitingINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

May 15, 2024

Study Completion Date

September 15, 2024

Conditions

Vascular DiseasesKidney DiseaseBlood PressureOxidative Stress

Interventions

DRUG

Nicotinamide riboside

Nicotinamide riboside is a naturally occurring vitamin B3 derivative found in yeast, bacteria, and mammalian tissues, and also has been detected in cows' milk.

Trial Locations (1)

80045

RECRUITING

UColorado, Aurora

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER